Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Wegovy GoodRx vs Savings Card: Which Is Cheaper in 2026?
articleComparing a Wegovy GoodRx coupon against the manufacturer savings card only makes sense once you know which eligibility class you fall into. This guide routes commercial, government, and self-pay patients to the right price, and flags which figures are current and which are a dated snapshot.
Wegovy Savings Card: How to Get $25/Month (2026 Guide)
articlePrescribed Wegovy for weight management? This guide walks the savings card eligibility tiers, enrollment steps, the most common pharmacy rejections, and the NovoCare self-pay alternative if the card is not an option for you.